These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1709302)

  • 1. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.
    Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J
    Science; 1991 May; 252(5007):839-42. PubMed ID: 1709302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.
    Michnick SW; Rosen MK; Wandless TJ; Karplus M; Schreiber SL
    Science; 1991 May; 252(5007):836-9. PubMed ID: 1709301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.
    Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J
    J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
    Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
    Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13.
    Jin YJ; Albers MW; Lane WS; Bierer BE; Schreiber SL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6677-81. PubMed ID: 1713687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing immunosuppressant action with a nonnatural immunophilin ligand.
    Bierer BE; Somers PK; Wandless TJ; Burakoff SJ; Schreiber SL
    Science; 1990 Oct; 250(4980):556-9. PubMed ID: 1700475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
    Heitman J; Movva NR; Hall MN
    Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the FK506 binding domain of human FKBP25 in complex with FK506.
    Prakash A; Rajan S; Yoon HS
    Protein Sci; 2016 Apr; 25(4):905-10. PubMed ID: 26749369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteronuclear 3D NMR studies of water bound to an FK506 binding protein/immunosuppressant complex.
    Xu RX; Meadows RP; Fesik SW
    Biochemistry; 1993 Mar; 32(10):2473-80. PubMed ID: 7680570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of FK506 bound to FKBP-12.
    Lepre CA; Thomson JA; Moore JM
    FEBS Lett; 1992 May; 302(1):89-96. PubMed ID: 1375171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains.
    DiLella AG; Craig RJ
    Biochemistry; 1991 Sep; 30(35):8512-7. PubMed ID: 1716149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands.
    Yu L; Fesik SW
    Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12.
    Lepre CA; Pearlman DA; Cheng JW; DeCenzo MT; Livingston DJ; Moore JM
    Biochemistry; 1994 Nov; 33(46):13571-80. PubMed ID: 7524662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR studies of an FK-506 analogue, [U-13C]ascomycin, bound to FKBP: conformation and regions of ascomycin involved in binding.
    Petros AM; Gampe RT; Gemmecker G; Neri P; Holzman TF; Edalji R; Hochlowski J; Jackson M; McAlpine J; Luly JR
    J Med Chem; 1991 Sep; 34(9):2925-8. PubMed ID: 1716684
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR.
    Petros AM; Kawai M; Luly JR; Fesik SW
    FEBS Lett; 1992 Aug; 308(3):309-14. PubMed ID: 1380470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.
    Meadows RP; Nettesheim DG; Xu RX; Olejniczak ET; Petros AM; Holzman TF; Severin J; Gubbins E; Smith H; Fesik SW
    Biochemistry; 1993 Jan; 32(3):754-65. PubMed ID: 7678499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.